schizophrenia, autism spectrum disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. People diagnosed with schizophrenia, schizoaffective disorder, delusional disorder, schizotypal disorder, or autism spectrum disorders according to DSM-5, or diagnosed with schizophrenia, schizoaffective disorders, persistent delusional disorders, schizotypal disorder, or pervasive developmental disorders according to ICD10. 3. People who fully briefed on the research and gave his/her written consent with full understanding
Exclusion criteria
Exclusion criteria: 1. People at high risk of violence, suicide attempts, or impulsive behavior 2. People with current substance or alcohol abuse 3. People with traumatic head injury, cerebrovascular disease, or neurodegenerative disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Social cognition [pre-intervention, post-intervention, follow-up (6 weeks after the end of intervention)]: Facial Emotion Recognition Task Reading the Mind in the Eyes Test Reading the Mind in Films Test Mayer-Salovey-Caruso Emotion Intelligence Test Gazefinder | — |
Secondary
| Measure | Time frame |
|---|---|
| Social functioning [pre-intervention, post-intervention, follow-up (6 weeks after the end of intervention), long-term follow-up (52 weeks after the end of intervention)]: Rosenberg Self-Esteem Scale Self-Consciousness Scale Interpersonal Reactivity Index Multidimensional Scale of Perceived Social Support UCLA Loneliness Scale Social Functioning Scale WHOQOL26 Composite Rating of Social Outcome Global Assessment of Functioning Neurocognition [pre-intervention, post-intervention, follow-up (6 weeks after the end of intervention)]: MATRICS Consensus Cognitive Battery Symptoms [pre-intervention, post-intervention, follow-up (6 weeks after the end of intervention)]: Positive and Negative Syndrome Scale Childhood Autism Rating Scale-Second edition Traits [pre-intervention, post-intervention, follow-up (6 weeks after the end of intervention), long-term follow-up (52 weeks after the end of intervention)]: Schizotypal Personality Questionnaire Autism-spectrum Quotient | — |
Countries
Japan
Contacts
Graduate School of Medicine, Kyoto University Department of Psychiatry